Robert L. Ferrara - 10 Jun 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
/s/ Robert L. Ferrara
Issuer symbol
PHIO
Transactions as of
10 Jun 2025
Net transactions value
+$6,050
Form type
4
Filing time
11 Jun 2025, 16:59:45 UTC
Previous filing
21 May 2025
Next filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ferrara Robert L Director C/O PHIO PHARMACEUTICALS CORP., 11 APEX DR., SUITE 300A, PMB 2006, MARLBOROUGH /s/ Robert L. Ferrara 11 Jun 2025 0001792987

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $6,050 +2,500 +19% $2.42 15,666 10 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.